Is Gabapentin Bad for You? Side Effects and Risks

Gabapentin is not inherently dangerous for most people who take it as prescribed, but it does carry real risks that depend on your dose, your other medications, and your overall health. It’s one of the most commonly prescribed drugs in the United States, used for nerve pain, seizures, and a long list of off-label conditions. Whether it’s “bad for you” comes down to specifics.

What Gabapentin Does in Your Body

Gabapentin works by binding to a specific part of calcium channels on nerve cells, which reduces the release of chemical signals involved in pain and overexcitement. Unlike many pain medications, it doesn’t work immediately. The drug needs to be taken up into cells through amino acid transporters before it starts having an effect, which is why doctors typically increase the dose gradually over days or weeks. It essentially dials down nerve activity rather than blocking pain signals outright.

Common Side Effects and How Often They Happen

The most frequent side effects are dizziness and drowsiness. In clinical trials for nerve pain, about 20% of people taking gabapentin at lower doses experienced dizziness (compared to 7% on placebo), and roughly 15% experienced sleepiness (compared to 6% on placebo). Interestingly, at higher doses of 1,800 mg per day or more, rates of dizziness and drowsiness were actually comparable to placebo, possibly because patients who couldn’t tolerate those effects had already dropped out at lower doses.

Swelling in the hands and feet is another dose-dependent side effect. At higher doses, about 7.5% of patients developed peripheral edema, compared to under 2% on placebo. Weight gain is possible but less common than many people fear. In clinical trials, only 2 to 3% of patients gained weight, and those who did typically gained about 5 pounds over six weeks.

The Opioid Combination Risk

The most serious safety concern with gabapentin involves taking it alongside opioid painkillers. A large population-based study found that people prescribed both gabapentin and opioids had a 49% higher risk of dying from an opioid overdose compared to those taking opioids alone. At moderate and high gabapentin doses, that risk climbed to nearly 60%. The combination can suppress breathing more than either drug would on its own.

The FDA has issued a specific warning about this. Serious breathing problems can occur when gabapentin is combined with opioids or other drugs that depress the central nervous system. People with lung conditions like COPD and older adults are at especially high risk. If you take gabapentin with any opioid, sedative, or sleep medication, this is the single most important risk to understand.

Long-Term Use and Brain Health

One common worry is whether years of gabapentin use might cause lasting cognitive problems or increase the risk of dementia. A large study using nearly two decades of health insurance data from over 200,000 chronic pain patients found no meaningful link. The adjusted odds ratio for dementia in gabapentin users was 0.91, which is statistically indistinguishable from no effect at all. There was no difference between low and high cumulative doses, and the finding held regardless of age or gender.

That said, gabapentin can cause temporary cognitive effects like confusion and difficulty concentrating, particularly when you first start it or increase the dose. These effects are usually reversible and tend to settle as your body adjusts.

Risks for Older Adults

Gabapentin is frequently prescribed to people over 65, and there’s been concern that it increases fall risk in this group due to dizziness and unsteadiness. A recent study published in Annals of Internal Medicine compared new gabapentin users to new users of duloxetine (another common pain medication) and found that gabapentin users actually had a lower rate of fall-related medical visits at six months. There was no significant difference in hip fractures or hospitalizations from falls between the two groups.

This doesn’t mean gabapentin is risk-free for older adults. The FDA still flags the elderly as higher risk for breathing problems, and kidney function declines with age, which directly affects how the drug is processed.

Kidney Function Matters

Gabapentin is eliminated almost entirely through the kidneys. If your kidneys aren’t working well, the drug builds up in your system and side effects intensify. Dosing needs to be significantly reduced as kidney function drops. Someone with normal kidney function might safely take up to 3,600 mg per day, while someone with moderately reduced function might need to stay under 900 mg. People on dialysis typically take very small doses only after treatment sessions. If you have any degree of kidney disease, your prescriber should be adjusting your dose accordingly.

Withdrawal Is Real

Gabapentin can cause physical dependence, and stopping abruptly can trigger withdrawal symptoms. These commonly include restlessness, anxiety, insomnia, sweating, nausea, headaches, and body pain. In more serious cases, withdrawal can cause heart palpitations, high blood pressure, depressed mood, and even seizures.

A safe taper typically takes at least three weeks, though some people need as long as 18 weeks to come off the drug comfortably. The higher your dose and the longer you’ve been taking it, the slower the taper should be. This is one of the most practically important things to know about gabapentin: never stop it suddenly, even if you feel fine.

Off-Label Prescribing Outpaces the Evidence

Gabapentin is FDA-approved for epilepsy and postherpetic neuralgia (nerve pain after shingles). But a huge portion of prescriptions are for off-label uses, including anxiety, depression, bipolar disorder, alcohol withdrawal, and general chronic pain. The evidence behind many of these uses is thin.

For anxiety disorders, the only randomized controlled trials have looked at situational anxiety like pre-surgery nervousness. No trials have tested gabapentin as a standalone or add-on treatment for generalized anxiety disorder or depression. Its reputation as a mood stabilizer for bipolar disorder has faded as newer research shows those effects are minimal to negligible. For alcohol use disorder, a systematic review concluded gabapentin may be safe as an add-on treatment but not as the primary therapy, and evidence for other substance use disorders is insufficient.

This matters because if gabapentin isn’t effectively treating your condition, you’re accepting side effects and withdrawal risk for limited benefit. If your prescription is for an off-label use, it’s worth understanding how strong the evidence actually is for your specific situation.

Who Should Be Most Careful

Gabapentin poses the greatest risk to people who fall into overlapping categories: those taking opioids or sedatives, those with reduced lung function, those with kidney impairment, and older adults who may check more than one of those boxes simultaneously. For a relatively healthy person taking gabapentin alone for an evidence-backed condition, the risk profile is modest. The drug doesn’t damage the liver, doesn’t appear to cause dementia, and its most common side effects are manageable and often temporary.

The real question isn’t whether gabapentin is universally “bad” but whether it’s the right fit for your particular health picture, and whether the condition it’s treating has solid evidence behind gabapentin as a treatment in the first place.